Can-One board accepts up to RM1b takeover offer

MIDF Research is negative on Can-One's mandatory general offer (MGO) for Kian Joo Can Factory Bhd (KJCF) as the price will be too steep and impact its gearing.

KUALA LUMPUR: Can manufacturer Can-One Bhd's board has accepted the takeover offer for its subsidiary  F&B Nutrition Sdn Bhd from  Asia Dairy Creations Sdn Bhd (ADCSB) valued at between RM800mil and RM1bil.

RHB Investment Bank Bhd, which issued the statement on behalf of Can-One, said the board has deliberated on the offer and accepted it. This was based on the terms and subject to the conditions as set out in the term sheet.

“The offer will be subject to a definitive agreement and other ancillary agreements being entered into between Can-One and ADCSB within 30 days from the date of acceptance of the offer, with an automatic extension for a further period of 30 days, or such further extension of time as the parties may mutually agree,” it said.

The offer entailed the acquisition by ADCSB of the entire issued share capital of F&B Nutrition from Can-One at an indicative consideration of between RM800mil and RM1bil.

F&B Nutrition makes dairy and non-dairy products and is an original equipment manufacturer of sweetened creamer and evaporated creamer. 

Can-One owns 20% of F&B Nutrition while the remaining 80% is held by Amber Alliance Sdn Bhd, a unit of Can-One.

ADCSB is a special purpose vehicle managed by Southern Capital.

RHB Investment Bank was appointed principal adviser to the company in respect of the offer. 

Can-One's share price jumped 28 sen to RM3.71 at midday on Tuesday.
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Business News

Binasat buys majority stake in solar contractor for RM18.36mil
Lalamove files confidentially for US$1bil US IPO
Serba Dinamik to decide on independent review scope on Friday
Scientex posts higher Q3 earnings, says Covid-19 lockdown to impact project billings�
FBM KLCI in the red as key heavyweights weigh
Singapore’s GIC buying 16% stake of Sunway Healthcare for RM750m
Moody's affirms Cagamas' A3 ratings; outlook stable
MGS yield curve steepened on lockdown due to infections surge
Euro zone business growth at 15-year high as demand unleashed -PMI
Pharmaniaga takes up financing facility under StanChart’s RM4.17b fund

Stories You'll Enjoy